The NIH Director's New Innovator Award Program (DP2 Clinical Trial Optional) is a funding opportunity provided by the National Institutes of Health. While specific details about eligibility, funding amount, and program goals are not provided, this award typically supports innovative research projects. The clinical trial optional designation indicates flexibility in research design.
Eligibility details are not specified in the grant listing. Contact the funding organization for requirements.
